LAIR2
Leukocyte-associated immunoglobulin-like receptor 2
You are using an outdated browser. Please upgrade your browser to improve your experience.
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
cell line | 0.52 | ||
cell type or tissue | 0.52 | ||
tissue | 0.46 | ||
small molecule perturbation | 0.43 | ||
chemical | 0.41 | ||
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
- OR - satisfy the following criterion:
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Target has at least one approved drug - AND - satisfies the preceding conditions
Click on a row in the table to change the structure displayed.
Data Source | Name | Explore in Pharos | Explore in Source | ||
---|---|---|---|---|---|
Reactome | Adaptive Immune System | ||||
Reactome | Immune System | ||||
Reactome | Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | ||||
Name | Explore in Pharos | Explore in Source | ||
---|---|---|---|---|
Adaptive Immune System | ||||
Immune System | ||||
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | ||||
GO Term | Evidence | Assigned by | ||
---|---|---|---|---|
Traceable Author Statement (TAS) | Reactome | |||
GWAS Trait | EFO ID | Study Count | SNP Count | Beta Count | Odds Ratio | Evidence (Mean Rank Score) | Provenance | ||
---|---|---|---|---|---|---|---|---|---|
self reported educational attainment | 1 | 1 | 1 | 45.7 | |||||
high density lipoprotein cholesterol measurement | 1 | 1 | 1 | 34.9 | |||||
apolipoprotein A 1 measurement | 1 | 1 | 1 | 32.9 | |||||
1 | 1 | 0 | 1.5 | 31.4 | |||||
GWAS Trait | EFO ID | Beta Count | Odds Ratio | Evidence (Mean Rank Score) | Provenance | ||
---|---|---|---|---|---|---|---|
self reported educational attainment | 1 | 45.7 | |||||
high density lipoprotein cholesterol measurement | 1 | 34.9 | |||||
apolipoprotein A 1 measurement | 1 | 32.9 | |||||
0 | 1.5 | 31.4 | |||||
PMID | Year | Title |
---|